Meet with NCI SBIR program director Deepa Narayanan and Liz Powell founder of G2G consulting at the SBIR/STTR Workshop hosted by Sterling Bay! This program will cover topics including SBIR/STTR funding opportunities, commercialization resources, tips for building a strong funding application, and review the NIH and CDC pre-solicitation to FY 2020 SBIR contract proposals. Following the presentation Deepa Narayanan and Liz Powell will hold 1on1 meetings with interested attendees.

More about the NCI 2020 SBIR Contract Proposals:

NIH and CDC pre-solicitation is anticipated to have a closing date of October 23, 2019 for receipt of proposals. Click here to see the solicitation. The following research topics are anticipated to be included in SBIR contract solicitation

• Manufacturing Innovation for the Production of Cell-Based Cancer Immunotherapies.
• Development of Senolytic Agents for Cancer Treatment.
• Combinatory Treatment Utilizing Radiation to Locally Activate Systemically Delivered Therapeutics.
• Sensing Tools to Measure Biological Response to Radiotherapy.
• Quantitative Biomimetic Phantoms for Cancer Imaging.
• Artificial Intelligence-Aided Imaging for Cancer Prevention, Diagnosis, and Monitoring.
• Spatial Sequencing Technologies with Single Cell Resolution for Cancer Research.
• Subcellular Microscopy and -Omics in Cancer Cell Biology.
• Intra-Tumor Sensing Technologies for Tumor Pharmacotyping.
• Software for Patient Navigation Through the Cancer Care Continuum.
• Cloud-Based Software for the Cancer Research Data Commons.
• Tools and Technologies for Visualizing Multi-Scale Data.
• Software for Automated Analysis of Images for Improved Cancer Health.
• Cancer Clinical Trials Recruitment and Retention Tools for Participant Engagement.
• De-Identification Software Tools for Cancer Imaging Research.
• Software Enabling Data Integration from Wearable Sensors for Cancer Patients.

The medical device industry is increasingly looking at new ways to sterilize their products.  Fermi National Accelerator Laboratory, in partnership with the Department of Energy, Baxter, and other organizations, is hosting a workshop on September 18-19 to discuss ways to unlock X-ray and E-Beam technologies as viable and scalable sterilization solutions.  The workshop will focus on the current state of medical device sterilization, educate participants on the fundamental principles, address what information is needed to ease regulatory approval, and how scientists and industry can work together toward a new industry standard. The schedule will alternate between presentations and moderated panel discussions in order to give all participants an opportunity to be involved in the discussion.

Fermilab has been tapped as a key partner to the federal government and industry in advancing the feasibility of particle accelerator-driven sterilization approaches. This work builds on our 50-year history of building and innovating these technologies for industry applications. Both Sterigenics and Steris will be speaking at the event and attendees include reps from Medtronic, J&J, BD, and other leading device companies and standards organizations. Bryon Lambert from Abbott will be the keynote. More details here.

The workshop goals include:

Join WIB for its fifth annual Start-Up Challenge as finalists from women-led Illinois biotech companies give a short pitch about their company’s technology and products.

Local experts from the investment and start-up communities will provide feedback and select the winning pitch, with the winner receiving a $2500 award sponsored by Horizon Pharma. The event will also feature a structured networking session with local entrepreneurs.

Interested in competing in the Challenge? All women-led companies are invited to apply to participate. This is a great opportunity to showcase your company and gain valuable feedback on your presentation. As a participant, WIB-Chicago is pleased to offer you private, one-on-one personalized coaching for your pitch. The application is available here until September 6, 2019.

Further questions? Email us: chicago@womeninbio.org

Program

  5:30 p.m. – 6:15 p.m. – Registration, Appetizers, and Networking
6:15 p.m. – 6:30 p.m. – Announcements and Introduction
6:30 p.m. – 8:00 p.m. – Pitch Presentations
8:00 p.m. – 8:30 p.m. – Awards, Closing Remarks, Dessert Reception

Pricing Information

Until September 10

• Members: $10
• Non-Members: $40

After September 10

• Members: $20
• Non-Members: $50

The MedTech Conference will bring together more than 3,000 attendees to network, conduct business, gain access to capital and share insights in Boston, MA, from September 23–25.

The iBIO iCON Awards recognize the vital roles that education, research and civic leadership play in fostering growth within the life sciences community. Each year, the iBIO hosts the iCON Awards Dinner to celebrate breakthrough achievements of teachers, researchers, entrepreneurs and civic leaders whose hard work and dedication inspire us all.

Have you ever wondered how your company can partner with the University of Illinois? Come visit our Technology Showcase and Open House!

On October 3, 2019 IBRL will partner with the Center for Advanced Bioenergy and Bioproduct Innovation (CABBI) to showcase the thriving and growing industrial biotech ecosystem at the U of I and in the state of Illinois. This event will allow you to meet other companies who are currently working with U of I and find out how it has benefitted them, see the pilot facilities that are ideal for scaling up technologies, and hear from some of the leading experts on where the future of biotech is headed.

What: Industrial Biotech Showcase and Open House

When: October 3, 2019 12:00pm – 6:30pm

Where: IBRL (1300 W. Pennsylvania Ave. Urbana, IL)

Cost: $500 per company. Includes registration for two company representatives

Agenda

12:00 – 1:30pm Buffet Lunch in ACES Library

Opening remarks from Dr. Evan DeLucia, CABBI Director & Dr. Vijay Singh, IBRL Director

1:30 – 3:00pm Choice of Tours:

• Institute for Genomic Biology
• Integrated Bioprocessing Research Lab & Food Science Human Nutrition Pilot Processing Plant
• Energy Farm

Tour Alternative: meeting with student talent ranging from undergraduates to post docs

3:30 – 6:30pm Biotechnology Showcase Including Remarks From:

Darren Streiler, Investment Director ADM Ventures

Dr. Yong-Su Jin, Professor of Food Microbiology

Dr. Tom Clemente, Eugene W. Price Distinguished Professor of Biotechnology , Center for Plant Science Innovation, University of Nebraska-Lincoln

Dr. Huimin Zhao, Steven L. Miller Chair Professor of Chemical and Biomolecular Engineering, University of Illinois

4:30 – 6:30pm Reception with passed Hours d’oeuvres, wine and beer

The Halo Awards is a first-of-its-kind Grammy-style event celebrating three Chicago scientists for their dedication to turning their research into treatments that help people live better lives. This is not your typical award show.

At the Halo Awards, the scientist is celebrity.

Watch 2018 Video

MCCS will host a Poster Session from 6:30 – 9:30pm Thursday evening October 17, 2019, at the Potocsnak Family Atrium in the new Simpson Querrey Biomedical Research Center at Northwestern University – 303 Superior St. Chicago, IL 60611

Abstract submissions are now open

The abstract deadline for those wanting to be considered for an oral presentation is September 9th, 2019. The deadline for submitting an abstract to present a poster is October 2nd, 2019. Registration is free but required for all participants, this includes those giving presentations.

Symposium event information and location will be updated as things are confirmed. Thank you for a wonderful 2018 Workshop in San Diego! We are looking forward to seeing you all in Chicago in October.

The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies. The event features plenary sessions, business roundtables and therapeutic workshops, company presentations, and BIO One-on-One Partnering™ meetings.

Program

The BIO Investor Forum delivers a rich program that features corporate presentations and panel debates on the sweet spots and growth challenges facing the industry.  The BIO Investor Forum features:

• Public and venture-stage company presentations.
• Expert-led panel discussions on the latest market and investment opportunities with emphasis on drug and technology development.
• BIO One-on-One Partnering™ meetings between biopharma executives and investors
• Premier opportunity to network with industry executives and investors focused exclusively on life sciences.

The ETA Group at Chicago Booth, the Polsky Center for Entrepreneurship and Innovation and the Kellogg Innovation & Entrepreneurship Initiative are delighted to host the 6th Annual Entrepreneurship through Acquisition Conference.

The Booth-Kellogg Entrepreneurship through Acquisition (ETA) Conference is an annual event that brings together search fund entrepreneurs, investors, MBA students, faculty, and other participants in the entrepreneurship through acquisition ecosystem to meet one another and share insights into this rapidly-growing area. This year’s conference will feature two distinct tracks: (1) Traditional ETA and (2) Alternative ETA. The Traditional ETA track will highlight ETA models employed by graduating students and young alumni, including traditional, self-funded, and incubated search funds. This track is tailored to undergraduate and MBA students as well as professionals looking to learn more about the ETA model and/or considering ETA as a potential career path. The Alternative ETA track will highlight alternative paths to ETA and the CEO role, market trends, and other important topics. Some panels in this track will be tailored to more experienced executives.

The conference is co-organized by Chicago Booth and Kellogg and offers the opportunity to meet industry experts and practicing entrepreneurs from across the country, who provide their perspectives on various aspects of the ETA model. Entrepreneurship through acquisition rests at the intersection of academia and the private sector, blending the vast knowledge and insight of academia with the wisdom and experience of practicing professionals.

CONFERENCE AGENDA:

9:00 – 9:30 am Registration and Breakfast

9:30 – 9:45 am Opening Remarks

10:00 – 10:45 am Track 1: ETA Career Path

10:00 – 10:45 amTrackt 2: Mid-Career Transition to CEO

10:45 – 11:00 am Break

11:00 – 11:45 am Track 1: The Investor Perspective

11:00 – 11:45 am Track 2: Women in ETA

12:00 – 1:00 pm Networking Lunch

1:00 – 1:45 pm Track 1: Working with the Owner

1:00 – 1:45 pm Track 2: ETA Trends and Updates

1:45 – 2:00 pm Break

2:00 – 2:45 pm Track 1: Young CEO Perspective

2:00 – 2:45 pm Track 2: Creating Value

2:45 – 3:00 pm Break

3:00 – 4:00 pmClosing Keynote with Eric Roza, CEO of DataLogix

4:00 – 5:30 pm Networking Reception (on-site)

Full details and more Information:www.etaconference.com

This seminar on veterinary medicine regulations will provide attendees with an understanding of FDA’s veterinary drug approval process.

The U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) is responsible for the approval of veterinary drug products intended for both family pets and food-producing animals. However, FDA does not regulate all products intended for animal use. Jurisdiction over animal products including licensed biologics such as vaccines is shared with a number of other federal agencies.

For example, animal vaccines, animal disease diagnostic devices and some animal biologics are regulated by the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service or APHIS; and products such as flea and tick collars are regulated by the Environmental Protection Agency.

This two day interactive course will cover:

• Premarket approval process
• Various sections of a New Animal Drug Application
• Strategies for navigating the FDA approval process

Learning Objectives:

• Understand how the U.S. Food and Drug Administration regulates veterinary drug product.
• Understand how FDA’s Center for Veterinary Medicine is organized.
• Discuss the process by which veterinary drug products are reviewed and approved.
• Learn how to open an INAD File and request fee waivers.
• Obtain a working knowledge of various sections included within an NADA.
• Develop a deep understanding of what is needed to substantiate product characterization, target safety and effectiveness.
• Gain general understanding of FDA’s rules governing chemistry, manufacturing and controls (CMC).
• Understand the various components of an animal field study to support product approval.
• Discuss the difference between FDA’s various user fees and fee waivers.
• Identify the elements of an FDA compliant label.
• Develop a corporate compliance strategy covering labeling, marketing and advertising.
• Explore problem solving methods to mitigate regulatory enforcement risks.
• Explain how jurisdiction is split between various Federal agencies in a certain cases.
• Learn how animal feed, veterinary devices, OTC drug products and nutritional supplement are regulated in the U.S.

Who Should Attend:

This course is designed for people tasked with developing and maintaining an animal health company’s product portfolio and responsible for overseeing a company’s regulatory strategies. This includes individuals responsible for overseeing regulatory affairs, developing veterinary drug products, evaluating new technologies or applications, and those tasked with ensuring corporate compliance.

Among others, this includes:

• Personnel new to the Animal Health Industry
• CRO professionals
• Entrepreneurs looking to add value to their products
• Regulatory professionals
• Compliance professionals
• U.S. Agents of Foreign Corporations
• Document control specialists
• Record retention specialists
• Legal Professionals
• Financial Advisors and Institutional Investors
• Consultants, Inspectors and cGxP Experts

For more information about this conference visit https://www.researchandmarkets.com/r/ugztf7